Pharmaceutical Composition Containing 2-{4-[N-(5,6-Diphenylpyrazin-2-Yl)-N-Isopropylamino]Butyloxy}-N-(Methylsulfonyl)Acetamide
Patent No. EP4331607 (titled "Pharmaceutical Composition Containing 2-{4-[N-(5,6-Diphenylpyrazin-2-Yl)-N-Isopropylamino]Butyloxy}-N-(Methylsulfonyl)Acetamide") was filed by Nippon Shinyaku on Dec 1, 2016. The application was issued on Apr 30, 2025.
Patent Summary
Patent Family
Patent Oppositions (2)
Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.
Dossier Documents
The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.
Date
Description
Get instant alerts for new documents
EP4331607
- Application Number
- EP23214939A
- Filing Date
- Dec 1, 2016
- Status
- Granted And Under Opposition
- Mar 28, 2025
- Publication Date
- Apr 30, 2025
- External Links
- Slate, Register , Google Patents